Clinical Trials Browser

INDUSTRY × Urogenital Diseases × Genitourinary × Clear all

Urogenital Diseases, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT07103018 2026-03-23

STRIKE-001

Phase 1 Recruiting

144 enrolled

Genitourinary

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

40 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases

NCT04575766 2023-08-09

A Study of FT-7051 in Men With MCRPC

Phase 1 Terminated

25 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases, Prostatic Neoplasms

NCT05889806 2023-06-05

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)

Enrolling by invitation

10,000 enrolled

GenitourinaryOther hematologic neoplasm

Urogenital Diseases, Autoimmune Diseases, Cardiovascular Diseases, Communicable Diseases, Digestive System Diseases, Kidney Diseases, Neoplasms, Hematologic Neoplasms

Clinical Trials

EV-309

STRIKE-001

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

A Study of FT-7051 in Men With MCRPC

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)